Milliman recently released a report on the clinical burden of hepatitis C in the United States, and reported a projected cost of $115 over the next decade. However, with the newest generation of medicines, hepatitis C could become a rare disease within 2 decades. How does the cost of treatment compare to the cost to cure? Find out more here. (Source: Holly Campbell, PhRMA, 9/24/15)
You are here: / / Possible $115 Billion Saved with Elimination of Hepatitis C in the U.S.